AAAAAA

   
Results: 1-18 |
Results: 18

Authors: Miller, MC O'Dowd, GJ Partin, AW Veltri, RW
Citation: Mc. Miller et al., Contemporary use of complexed PSA and calculated percent free PSA for early detection of prostate cancer: Impact of changing disease demographics, UROLOGY, 57(6), 2001, pp. 1105-1111

Authors: Veltri, RW Miller, MC An, G
Citation: Rw. Veltri et al., Standardization, analytical validation, and quality control of intermediate endpoint biomarkers, UROLOGY, 57(4A), 2001, pp. 164-170

Authors: Veltri, RW Miller, MC Partin, AW Poole, EC O'Dowd, GJ
Citation: Rw. Veltri et al., Prediction of prostate carcinoma stage by quantitative biopsy pathology, CANCER, 91(12), 2001, pp. 2322-2328

Authors: Prescott, JL Montie, J Pugh, TW McHugh, T Veltri, RW
Citation: Jl. Prescott et al., Clinical sensitivity of p53 mutation detection in matched bladder tumor, bladder wash, and voided urine specimens, CANCER, 91(11), 2001, pp. 2127-2135

Authors: Ng, AY Bales, W Veltri, RW
Citation: Ay. Ng et al., Phenylbutyrate-induced apoptosis and differential expression of Bcl-2, Bax, p53 and Fas in human prostate cancer cell lines, ANAL QUAN C, 22(1), 2000, pp. 45-54

Authors: Veltri, RW Partin, AW Miller, MC
Citation: Rw. Veltri et al., Quantitative nuclear grade (QNG): A new image analysis-based biomarker of clinically relevant nuclear structure alterations, J CELL BIOC, 2000, pp. 151-157

Authors: O'Dowd, GJ Miller, MC Orozco, R Veltri, RW
Citation: Gj. O'Dowd et al., Analysis of repeated biopsy results within 1 year after a noncancer diagnosis, UROLOGY, 55(4), 2000, pp. 553-558

Authors: O'Dowd, GJ Miller, MC Orozco, R Veltri, RW
Citation: Gj. O'Dowd et al., Analysis of repeated biopsy results within 1 year after a noncancer diagnosis - Reply, UROLOGY, 55(4), 2000, pp. 559-559

Authors: Marks, LS Partin, AW Epstein, JI Tyler, VE Simon, I Macairan, ML Chan, TL Dorey, FJ Garris, JB Veltri, RW Santos, PBC Stonebrook, KA deKernion, JB
Citation: Ls. Marks et al., Effects of a saw palmetto herbal blend in men with symptomatic benign prostatic hyperplasia, J UROL, 163(5), 2000, pp. 1451-1456

Authors: An, G Ng, AY Meka, CSR Luo, GZ Bright, SP Cazares, L Wright, GL Veltri, RW
Citation: G. An et al., Cloning and characterization of UROC28, a novel gene overexpressed in prostate, breast, and bladder cancers, CANCER RES, 60(24), 2000, pp. 7014-7020

Authors: Veltri, RW
Citation: Rw. Veltri, Serum PSA - What are the clinical indications for using serum prostate specific antigen (PSA) biomarker?, LAB MED, 31(5), 2000, pp. 253-254

Authors: Reckwitz, T Potter, SR Snow, PB Zhang, Z Veltri, RW Partin, AW
Citation: T. Reckwitz et al., Artificial neural networks in urology: Update 2000, PROSTATE C, 2(5-6), 1999, pp. 222-226

Authors: Veltri, RW
Citation: Rw. Veltri, Molecular staging of prostate cancer: Dream or reality? The de la Taille/Olsson/Katz article reviewed, ONCOLOGY-NY, 13(2), 1999, pp. 205

Authors: An, G Meka, CSR Bright, SP Veltri, RW
Citation: G. An et al., Human prostate-specific transglutaminase gene: Promoter cloning, tissue-specific expression, and down-regulation in metastatic prostate cancer, UROLOGY, 54(6), 1999, pp. 1105-1111

Authors: Potter, SR Miller, MC Mangold, LA Jones, KA Epstein, JI Veltri, RW Partin, AW
Citation: Sr. Potter et al., Genetically engineered neural networks for predicting prostate cancer progression after radical prostatectomy, UROLOGY, 54(5), 1999, pp. 791-795

Authors: Veltri, RW Miller, MC
Citation: Rw. Veltri et Mc. Miller, Free/total PSA ratio improves differentiation of benign and malignant disease of the prostate: Critical analysis of two different test populations, UROLOGY, 53(4), 1999, pp. 736-745

Authors: Veltri, RW Miller, MC Zhao, G Ng, A Marley, GM Wright, GL Vessella, RL Ralph, D
Citation: Rw. Veltri et al., Interleukin-8 serum levels in patients with benign prostatic hyperplasia and prostate cancer, UROLOGY, 53(1), 1999, pp. 139-147

Authors: An, G Cazares, L Luo, GZ Miller, MC Wright, GL Veltri, RW
Citation: G. An et al., Differential expression of full-length and a truncated Her-2/neu oncogene receptor in prostate cancer assessed using relative quantitative RT-PCR, MOL UROL, 2(4), 1998, pp. 305-310
Risultati: 1-18 |